Myelofibrosis
📧 Sign up to get email alerts when something new happens for Myelofibrosis.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2026-03-18FDA Approved: INREBIC — Supplemental Application (Celgene Corporation)
FDA approved a supplemental application for INREBIC (fedratinib hydrochloride) submitted by Celgene, resulting in an updated label for the p…
-
FDA label_change · 2023-05-15FDA Approved: INREBIC — Supplemental Application (Celgene Corporation)
FDA notice of a supplemental application for INREBIC (fedratinib hydrochloride) submitted by Celgene Corporation; the submission status is A…